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1 Introduction
The case-control study design is often used in various types of epidemiological studies, including
genetic epidemiology. A case-control study is advantageous over a cohort study in that the
collection of samples can be performed in a short period of time. Moreover, the difficulty of
controlling for confounding factors and inferring causal relations is its primary disadvantage.
In addition, prevalence of the medical endpoints cannot be estimated. Despite those drawbacks
and in light of the efficiency, many genetic and genomic association studies employ the case-
control study design in the discovery stage to find genetic or genomic markers associated
with the medical endpoints of interest [1, 2]. The molecular markers can be single nucleotide
polymorphisms (SNP), mRNA expression profiles, or protein expression profiles. If the goal
of the study is to form a molecular diagnostic/prognostic, the associated markers will often be
combined to form a classifier/predictor.
While the diagnostic accuracy of a molecular test will ultimately be evaluated in a prospec-
tive clinical study with representative sample from the target population, it is very helpful to
evaluate the diagnostic values of genetic markers in discovery research phase using case-control
samples [3]. This can aid in the decision of which markers to follow in replication studies. Upon
replication, estimation of diagnostic values can help one decide whether to develop a molecular
diagnostic test and to go forward with an expensive clinical trial. The accuracy of a binary-
scale diagnostic test can be represented by sensitivity (Se), specificity (Sp) and positive and
negative predictive values (PPV and NPV ). Although Se and Sp measure the intrinsic ac-
curacy of a diagnostic test that does not depend on the prevalence rate, they do not provide
information on the diagnostic accuracy on a particular patient. To get this information we
need to employ PPV or NPV . Since PPV and NPV are functions of both the inherent
accuracy of the test and the prevalence of the disease, constructing confidence intervals for
PPV and NPV for a particular patient is not straightforward, regardless of the study design.
In this paper, we will derive a new formula for constructing such confidence intervals.
It has been known, due to the discreteness and skewness of the binomial distribution, that
the standard estimation of binomial proportions, Se and Sp in our case, and the subsequent
confidence interval generation of these proportions is less than adequate, especially when the
proportion being estimated is near 0 or 1. This estimation process leads to an oscillatory
pattern of coverage probabilities when certain parameters are slightly perturbed. Certain
combinations of sample size and prevalence can cause this oscillation to extend well below the
nominal coverage probability [4]. Because of this, the standard estimates of PPV and NPV
may fail to meet expectations, as well as their associated confidence intervals.
To correct for these problems, a continuity correction is incorporated into the estimation
of Se and Sp. This has been shown to greatly improve coverage probability of binomial pro-
portions and we will show that with a better estimate of Se and Sp, more accurate confidence
intervals can be developed [4]. Specifically, we will develop two types of confidence intervals.
The first of these methods includes the standard confidence interval while the other will utilize
the logit transformation. This transformation is used to help achieve normality and alleviate
problems associated with estimating proportions near the boundary values of 0 and 1[5].
Standard estimates of Se, Sp, PPV and NPV as well as adjusted estimates of each are
derived in Section 2. Section 3 details a simulation to assess each of these in terms of coverage
probability and confidence interval length. These methods are applied to two case-control
studies: a diagnostic test for late-onset Alzheimer’s disease (AD) and a prognostic test for
metastasis in breast cancer patients in Section 4.
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2 Methods
2.1 Estimation of PPV and NPV
Regardless of the study design that was used to evaluate a diagnostic test, the estimation
sensitivity and specificity is straightforward. If a case-control study design is used to evaluate
the test, then additional information, namely the prevalence of the disease in the population,
is needed to calculate the predictive values of the test. Typically this is required due to
the oversampling of one group over the other as denoted by n1 and n0 which represent the
numbers of cases and controls, respectively. Therefore, throughout this section the prevalence
is either assumed to be estimated from the observed data, as with a cohort study, or obtained
from an additional source, as with a case-control study. The information from either of these
observational studies is summarized by the contingency table below (Table 1).
Table 1: Standard contingency table
Disease + Disease -
Test + x11 x10
Test - x01 x00
n1 n0
Sensitivity and specificity of the test in this population will be denoted by Se and Sp and are
estimated from Table 1 by (1).
Ŝe =
x11
n1
, Ŝp =
x00
n0
(1)
It is of interest to estimate the positive and negative predictive values of a test, PPV and
NPV , in a prospective population with a given disease prevalence rate of p. Since Se and
Sp of a test are intrinsic and do not depend on the disease prevalence, we can assume that
Se and Sp of the test in the case-control population are the same as those in the prospective
population, which is already assumed when performing a cohort study. The formulas for PPV
and NPV of the test in the prospective population are:
PPV =
Se · p
Se · p+ (1− Sp) · (1− p) , NPV =
Sp · (1− p)
(1− Se) · p+ Sp · (1− p) . (2)
Their logit transformations are:
logit (PPV ) = log
[
Se · p
(1− Sp)(1− p)
]
, logit (NPV ) = log
[
Sp · (1− p)
(1− Se) · p
]
(3)
After obtaining the standard estimates of Se and Sp (1), the standard estimates for PPV and
NPV are found by replacing Se and Sp in (2) with Ŝe and Ŝp.
To adjust for the inherent drawbacks of the estimation of a binomial proportion, a continuity
correction is added to each cells of Table 1, resulting in Table 2. The addition of a constant,
k2
2 where k = z1−α2 = Φ
−1 (1− α2) and Φ−1(x) denotes the xth quantile of the inverse normal
distribution, is related to the Wilson estimation method for finding the midpoint of a skewed
distribution [4].
Table 2: Adjusted contingency table using a continuity correction
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Disease + Disease -
Test + x11 + k
2
2 x10 +
k2
2
Test - x01 + k
2
2 x00 +
k2
2
n˜1 = n1 + k2 n˜0 = n0 + k2
Using Table 2, adjusted estimates of Se and Sp are:
S˜e =
n1 · Ŝe+ k22
n˜1
, S˜p =
n0 · Ŝp+ k22
n˜0
(4)
With the adjusted estimates of Se and Sp, using (2) we can obtain adjusted estimates for
PPV and NPV . Using these estimates, four different confidence intervals will be constructed.
2.2 Confidence Intervals of PPV and NPV
The 100 (1− α)% confidence intervals that are generated follow the Wald type formulation:
A±z1−α
2
√
V ar (A), where A is the function being estimated. In this paper, A will include the
standard and adjusted estimates of PPV and NPV , as well as their logit transformations. All
confidence intervals will be represented by the estimation method of PPV/NPV . For example,
if the standard estimate of PPV is calculated and the logit transformation is then performed,
then the associated interval is deemed the standard logit interval. Other confidence intervals
exist for binomial proportions, such as Wilson’s interval and Jefferys interval, but these were
not pursued due to the possibility of having more than two roots and not being able to use
beta distribution as a prior, respectively.
The variances of each estimate is derived to complete the above formulation of the confi-
dence intervals. Via the binomial theorem, the variance of Se and Sp are:
V ar(Se) =
Se · (1− Se)
n1
, V ar(Sp) =
Sp · (1− Sp)
n0
(5)
The delta method was applied to determine the variances of PPV and NPV :
V ar(PPV ) =
[p · (1− Sp) · (1− p)]2 · Se·(1−Se)n1 + [p · Se · (1− p)]
2 · Sp·(1−Sp)n0
[Se · p+ (1− Sp) · (1− p)]4 (6)
V ar(NPV ) =
[Sp · (1− p) · p]2 · Se·(1−Se)n1 + [(1− Se) · (1− p) · p]
2 · Sp·(1−Sp)n0
[(1− Se) · p+ Sp · (1− p)]4 (7)
The variance of the logit(PPV ) and logit(NPV ) can be found in a similar manner.
V ar(logit(PPV )) =
[
1− Se
Se
]
· 1
n1
+
[
Sp
1− Sp
]
· 1
n0
(8)
V ar(logit(NPV )) =
[
Se
1− Se
]
· 1
n1
+
[
1− Sp
Sp
]
· 1
n0
(9)
The variances of the standard and adjusted methods can be fashioned by replacing PPV and
NPV with their respected estimates.
As previously mentioned, the 100(1− α)% confidence intervals for PPV and logit(PPV )
are:
PPV ± z1−α
2
√
V ar(PPV ), logit(PPV )± z1−α
2
√
V ar(logit(PPV )) (10)
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For interpretability purposes, as well as for the comparison of estimation methods, the intervals
for the logit transformed PPV estimates can be retransformed to their original scale:
PPV :
 elogit(PPV )−z1−α2√V ar(logit(PPV ))
1 + elogit(PPV )−z1−α2
√
V ar(logit(PPV )
,
e
logit(PPV )+z1−α2
√
V ar(logit(PPV )
1 + elogit(PPV )+z1−α2
√
V ar(logit(PPV )
 (11)
Similar intervals for NPV and logit(NPV ) are obtained by replacing PPV with NPV in (10)
and (11). Again, the evaluation of the following intervals using standard or adjusted estimates
will create the standard logit or adjusted logit intervals.
Using the developed results, a simulation study was performed to determine which method
is superior based on the criteria of confidence interval length and coverage probability.
3 Simulation
3.1 Description
In this section we discuss the results from a simulation that assesses the coverage probabil-
ity and confidence interval length of three proposed methods in comparison to the standard
method. There were 36 different combinations for the prevalence, p, (0.05, 0.30, 0.50), Se
(0.55, 0.75, 0.85, 0.90), and Sp (0.70, 0.85, 0.90), but only 12 will be discussed in this paper, as
seen in Table 3. Values and combinations of p, Se, and Sp were determined to roughly mimic
the examples of Section 4 as well as providing a more general parameter set in which other
studies may find appropriate. Other results not explicity detailed can be obtained from the
author.
Table 3: Design configurations for the simulation
Design (p, Se, Sp) Design (p, Se, Sp) Design (p, Se, Sp)
1 (0.05, 0.55, 0.70) 5 (0.30, 0.55, 0.70) 9 (0.50, 0.55, 0.70)
2 (0.05, 0.75, 0.85) 6 (0.30, 0.75, 0.85) 10 (0.50, 0.75, 0.85)
3 (0.05, 0.85, 0.90) 7 (0.30, 0.85, 0.90) 11 (0.50, 0.85, 0.90)
4 (0.05, 0.90, 0.70) 8 (0.30, 0.90, 0.70) 12 (0.50, 0.90, 0.70)
Four different values for n0 and n1,(25,50,100,400), were used with each design and were chosen
to reflect the examples of Section 4, but also to symbolize small, medium and large study sizes.
For each of the designs and n0 and n1 combination, 10,000 binomial samples were generated
using rbinom in R [6]. With these data, standard contingency tables were generated. From
the standard contingency tables, the continuity correction was added to each cell to create the
adjusted contingency tables (Table 2).
True PPV and NPV values were calculated corresponding to a given set of p, Se, and Sp.
This was followed by estimating PPV and NPV via the four previously derived methods.
Confidence interval lengths and coverage probabilities were then calculated. The possibility of
obtaining a standard estimate of PPV or NPV of 1 led to the potential problem of division by
zero when applying the logit transformation. Throughout these simulations when this occured
the point estimate and its confidence interval were coded as ’NA’ and thus the confidence
interval length and coverage probabilty were not applicable. The number of times this occurred
was recorded for further analysis when the methods were compared. It was also a possibilty that
the calculated confidence intervals extended outside their allowed bounds, [0, 1]. Throughout
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these simulations these occurances were noted, but not modified so that the [0, 1] condition
was not forced to be satisfied.
Simulation results for PPV and NPV can be found in Tables 4 & 5 and Tables 6 & 7,
respectively, where each table respresents either confidence interval length or coverage prob-
ability summaries for each predictive value. Due to the number of input parameters of this
simulation and the number of possible values of each parameter, these tables were constructed
by holding one parameter constant and averaging over the remaining parameters. For exam-
ple, if p is fixed at 0.05, then the interval lengths and coverage probabilites associated with
this prevalence value are the average of all possible design and (n0, n1) configuration’s interval
lengths and coverage probabilities with p = 0.05, ie: (p=0.05, Se=0.55, Sp=0.70, n0=100,
n1=100), (p=0.05, Se=0.75, Sp=0.85, n0=25, n1=400), etc. In Tables 4-7, the rows associ-
ated with Se = 0.70 and Sp = 0.85, as well as Se = 0.85 and Sp = 0.90 are identical due
to the design configuration of Table 3. The values were not omitted due to the increased
interpretability when included.
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Table 4: Summary of PPV coverage probabilities where the cell values denote the coverage
probability for a fixed design parameter and averaging over the remaining parameters.
Design parameter Standard Standard Logit Adjusted Adjusted logit
p = 0.05 0.9351 0.9540 0.8900 0.9203
p = 0.30 0.9328 0.9536 0.9300 0.9200
p = 0.50 0.9321 0.9536 0.9425 0.9198
Se = 0.55 0.9422 0.9515 0.9406 0.9517
Se = 0.75 0.9286 0.9558 0.9156 0.9137
Se = 0.85 0.9213 0.9577 0.9000 0.8818
Se = 0.90 0.9412 0.9499 0.9271 0.9329
Sp = 0.70 0.9417 0.9507 0.9338 0.9423
Sp = 0.85 0.9286 0.9558 0.9156 0.9137
Sp = 0.90 0.9213 0.9577 0.9000 0.8818
n0 = 25 0.9104 0.9566 0.8920 0.8862
n0 = 50 0.9325 0.9552 0.9163 0.9171
n0 = 100 0.9426 0.9521 0.9291 0.9304
n0 = 400 0.9478 0.9509 0.9459 0.9465
n1 = 25 0.9343 0.9539 0.9184 0.9183
n1 = 50 0.9337 0.9548 0.9206 0.9210
n1 = 100 0.9332 0.9536 0.9208 0.9195
n1 = 400 0.9320 0.9527 0.9235 0.9214
Overall 0.9333 0.9537 0.9208 0.9200
Table 5: Summary of PPV confidence interval lengths where the cell values denote the
confidence interval length for a fixed design parameter and averaging over the remaining
parameters.
Design parameter Standard Standard Logit Adjusted Adjusted logit
p = 0.05 0.1819 0.1771 0.1409 0.1398
p = 0.30 0.2234 0.2237 0.2138 0.2102
p = 0.50 0.1587 0.1630 0.1579 0.1583
Se = 0.55 0.1677 0.1656 0.1545 0.1528
Se = 0.75 0.2120 0.2110 0.1891 0.1876
Se = 0.85 0.2300 0.2338 0.2067 0.2051
Se = 0.90 0.1423 0.1414 0.1330 0.1322
Sp = 0.70 0.1550 0.1535 0.1438 0.1425
Sp = 0.85 0.2120 0.2110 0.1891 0.1876
Sp = 0.90 0.2300 0.2338 0.2067 0.2051
n0 = 25 0.2916 0.2938 0.2498 0.2465
n0 = 50 0.2143 0.2127 0.1948 0.1934
n0 = 100 0.1557 0.1550 0.1488 0.1482
n0 = 400 0.0904 0.0902 0.0900 0.0898
n1 = 25 0.2006 0.2002 0.1846 0.1828
n1 = 50 0.1896 0.1896 0.1727 0.1713
n1 = 100 0.1833 0.1834 0.1658 0.1645
n1 = 400 0.1784 0.1785 0.1604 0.1592
Overall 0.1880 0.1879 0.1708 0.1695
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From Tables 4 & 5, the estimation of PPV via the standard logit method is ’superior’ to
the other tested methods in terms of coverage probabilities with an overall value of 0.9537
and the adjusted logit method generated the shortest interval length of 0.1695. Overall, the
standard estimation methods yielded higher coverage probabilities along with having slightly
longer interval lengths than the adjusted methods. Among the methods investigated, the
interval lengths were fairly uniform only differing by at most ∼ 0.02, but only the standard
logit method attained the desired 95% nominal level. In terms of the parameters, typically
only the numbers of cases and controls (n1, n0) had a clear effect on the coverage probability
and interval length, while p, Se, and Sp fluctuated.
Regardless of n0 or n1, as either increased the interval length decreased among all estima-
tion methods. The increase of n1 did not drastically effect the coverage probabilities for the
standard methods, but a slight increase was noted for the adjusted methods. The increase in
p only had a positive effect on the adjusted logit coverage probability, while the other methods
remained relatively unchanged. There was not a clear effect of the increase in prevalence on
interval length. As Se increased, coverage probabilities tended to decrease except for the stan-
dard logit method where a minuscule increase was noted and their associated interval lengths
tended to increase regardless of the estimation method. These previous observations were
deviated from when Se = 0.90 where the opposite effect was observed. As with Se, similar
patterns were observed with an increase of Sp.
Table 6: Summary of NPV coverage probabilities where the cell values denote the coverage
probability for a fixed design parameter and averaging over the remaining parameters.
Design parameter Standard Standard Logit Adjusted Adjusted logit
p = 0.05 0.9333 0.9543 0.9608 0.9212
p = 0.30 0.9334 0.9538 0.9533 0.9202
p = 0.50 0.9342 0.9540 0.9440 0.9207
Se = 0.55 0.9442 0.9497 0.9576 0.9559
Se = 0.75 0.9387 0.9528 0.9499 0.9315
Se = 0.85 0.9278 0.9558 0.9488 0.9025
Se = 0.90 0.9238 0.9578 0.9545 0.8929
Sp = 0.70 0.9340 0.9537 0.9560 0.9244
Sp = 0.85 0.9387 0.9528 0.9499 0.9315
Sp = 0.90 0.9278 0.9558 0.9488 0.9025
n0 = 25 0.9333 0.9548 0.9587 0.9186
n0 = 50 0.9341 0.9544 0.9525 0.9218
n0 = 100 0.9342 0.9534 0.9503 0.9203
n0 = 400 0.9329 0.9536 0.9492 0.9221
n1 = 25 0.9172 0.9548 0.9483 0.8888
n1 = 50 0.9297 0.9561 0.9508 0.9148
n1 = 100 0.9410 0.9541 0.9541 0.9324
n1 = 400 0.9466 0.9512 0.9576 0.9468
Overall 0.9336 0.9540 0.9527 0.9207
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Table 7: Summary of NPV confidence interval lengths where the cell values denote the
confidence interval length for a fixed design parameter and averaging over the remaining
parameters.
Design parameter Standard Standard Logit Adjusted Adjusted logit
p = 0.05 0.0135 0.0145 0.0140 0.0147
p = 0.30 0.0855 0.0903 0.0877 0.0899
p = 0.50 0.1490 0.1540 0.1498 0.1506
Se = 0.55 0.0944 0.0940 0.0917 0.0913
Se = 0.75 0.0828 0.0839 0.0818 0.0823
Se = 0.85 0.0725 0.0767 0.0747 0.0765
Se = 0.90 0.0810 0.0906 0.0871 0.0901
Sp = 0.70 0.0877 0.0923 0.0894 0.0907
Sp = 0.85 0.0828 0.0839 0.0818 0.0823
Sp = 0.90 0.0725 0.0767 0.0747 0.0765
n0 = 25 0.0897 0.0934 0.0930 0.0942
n0 = 50 0.0834 0.0871 0.0848 0.0860
n0 = 100 0.0801 0.0837 0.0805 0.0817
n0 = 400 0.0773 0.0809 0.0770 0.0782
n1 = 25 0.1252 0.1359 0.1267 0.1294
n1 = 50 0.0936 0.0963 0.0946 0.0961
n1 = 100 0.0699 0.0707 0.0710 0.0716
n1 = 400 0.0421 0.0422 0.0430 0.0431
Overall 0.0827 0.0863 0.0838 0.0850
From Tables 6 & 7, overall coverage probabilities and intervals lengths of the standard logit,
(0.9540, 0.0863), and adjusted, (0.9527, 0.0838), estimation methods were virtually identical
and only differed after the hundreths digit and thus were considered the ’superior’ estima-
tion methods of NPV ’s. Both of these methods attained the desired 95% threshold while
maintaining interval lengths comparable to the other methods.
As with the PPV estimates, the increase of n0 and n1 clearly decreased all NPV interval
lengths. Contrary to the PPV estimates, the increase of n0 did not drastically alter the
NPV ’s coverage probabilities among the estimation methods, but the increase of n1 increased
coverage probabilities for all estimation methods except of the standard logit method. The
increase of p only appeared to have a noticeable negative effect on the coverage probability
of the adjusted method, whereas other methods remained unchanged. The interval lengths
greatly increased with the increase of p, but all methods increased at the same rate. As Se
increased, the coverage probabilities decreased except for the standard logit method and for
all methods the interval length decreased. Similar results for the increase of Sp are observed
for interval length, while coverage probabilities remain relatively unchanged except for a slight
decrease with the adjusted method.
Superior is conveniently placed in quotes due to previously mentioned caveat that if esti-
mates of PPV and NPV are 1, then the standard logit method is not applicable. Throughout
this simulation study whichever iteration generated this estimate of PPV orNPV the standard
logit method would be skipped with the total number of skipped iterations being tallied. Many
factors contribute to the occurrence of a predictive value estimate of 1, such as n0, n1, Se, and
Sp. It was noted that many of the parameter configurations did not generate these estimated
values, but of those that did the percentage of problematic estimates was as high as ∼ 7.5%.
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For PPV estimates, these typically occurred when n0 was small, 25, and Sp > Se, with both
Sp and Se being large, 0.90 and 0.85. Similar occurrences happened with NPV estimates, but
n1 was small, 25, and Se > Sp, 0.90 and 0.70. Even though various proportions of iterations
were not executed, the sample size of each simulation was large enough that the results of the
standard logit method remained valid.
In addition to having the standard logit method not being able to be computed, the over-
flowing of intervals lower than 0 and greater than 1 was a significant problem with the untrans-
formed standard and adjusted methods. For the standard, untransformed interval estimate
of PPV , the upper interval estimate exceeded the 1 up to 47% of the iterations for a single
parameter configuration. This remarkably high percentage of non-nonsensical confidence in-
tervals typically stemmed from a small n0 value, 25, and large values of Se and Sp, 0.85 and
0.90. Under similar parameter configurations, the adjusted, untransformed estimates of PPV
produced these types of intervals, but not of the magnitude of the standard estimates, ∼ 7.5%.
This phenomenon was observed with the estimation of NPV as well. Large values of Se
and Sp, 0.85 and 0.90, along with a small n1 value, 25, resulted in the standard, untransformed
upper interval estimate of NPV exceeding 1 46% of the total number of iterations. When the
combination of Se and Sp was changed to 0.90 and 0.70, this percentage increased to 69%
when n1 was 25. The adjusted, untransformed upper limit estimate of NPV resulted in 1
being exceeded 9% and 27% using the previously mentioned design configurations. Based on
these observations, the results of the standard logit method, as well as the untransformed
standard and adjusted methods need to be approached cautiously.
Each evaluated method produced comparable interval lengths and thus the preferred method
would be able to be constantly applied, regardless of estimate value, as well as producing
meaningful interval ranges and have a coverage probability that asymptotically attains the
95% desired threshold. None of the evaluated methods meet all of these ideal criteria, but
if the standard estimates of the predictive values is not 1, then the standard logit method is
recommended.
4 Applications
To illustrate the utility of the above methods to estimate predictive values and their confi-
dence intervals, two examples in molecular diagnostics and prognostics will be examined. The
first example is to estimate predictive values using the e4 allele of the apolipoprotein E gene
(ApoE.e4) as a molecular diagnostic for Alzheimer’s disease, (AD). The second example is the
use of a gene-expression signature as prognosticator for metastasis of breast cancer tumors.
4.1 Alzheimer’s Disease
Alzheimer’s disease (AD) is a common disease among elderly individuals. The prevalence
of AD depends upon age which ranges between 3% to 50% among individuals between the
ages of 65 and 90 [7, 8]. Improving the diagnostic accuracy of AD will aid in the early and
correct identification of proper treatment regimes. It has been well established that ApoE.e4
is associated with an increased susceptibility to AD [9, 10, 11]. Studies have also been carried
out to evaluate the usefulness of ApoE.e4 genotype in the diagnosis of AD among persons
with dementia [12]. The general conclusion is that while ApoE.e4 genotyping does not provide
sufficient Se and Sp to be used alone as a diagnostic test for AD, but when in combination
with clinical criteria, it improves the Sp of the diagnosis. Diagnostic utility of genotyping
10
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tests can also be improved when additional susceptibility genes are found and added to the
diagnostic genotyping panel [13].
Li et al. have recently performed a case-control study to identify other susceptibility genes
for AD [1]. This Washington University study recruited 418 cases and 375 controls, with a
known ApoE genotype, of which 240 of the cases and 87 of the controls carried at least one
ApoE.e4 allele. A positive molecular diagnostic for AD was defined if the ApoE.e4 allele was
present and negative if absent. These data are summarized in Table 8.
Table 8: Alzheimer’s Disease data
Case Control
ApoE.e4 + 240 87
ApoE.e4 - 178 288
418 375
From Table 8, Se of the APoE.e4 genotyping test is estimated to be 0.574 (95% CI 0.526-
0.621) while the Sp is estimated to be 0.768 (95% CI 0.723-0.808) using the standard method.
Moreover, PPV and NPV cannot be directly estimated from the above table due to the
study design. Cases have been oversampled (52.7% of the whole sample) as compared to the
prevalences in the general population, especially in the younger age group.
Using disease prevalence of 3% and 50%, estimates of PPV andNPV , their 95% confidence
intervals and interval lengths were calculated using the four described methods. These results
are summarized in Table 9.
Table 9: Alzheimer’s Disease Results
PPV a PPV b
Method Estimate 95% CIc CI Length Estimate 95% CI CI Length
Standard 0.0711 0.0578-0.0844 0.0267 0.7122 0.6709-0.7536 0.0827
Standard Logit 0.0711 0.0589-0.0856 0.0268 0.7122 0.6692-0.7518 0.0826
Adjusted 0.0703 0.0572-0.0833 0.0261 0.7096 0.6685-0.7507 0.0823
Adjusted Logit 0.0703 0.0583-0.0845 0.0262 0.7096 0.6668-0.7489 0.0821
NPV a NPV b
Standard 0.9831 0.9811-0.9852 0.0041 0.6433 0.6147-0.6719 0.0571
Standard Logit 0.9831 0.9809-0.9851 0.0041 0.6433 0.6143-0.6713 0.0570
Adjusted 0.9831 0.9810-0.9851 0.0041 0.6421 0.6137-0.6706 0.0570
Adjusted Logit 0.9831 0.9809-0.9850 0.0041 0.6421 0.6132-0.6701 0.0569
a Prevalence = 0.03; b Prevalence = 0.50; c CI = confidence interval
The standard methods, both transformed and untransformed, usually produced a larger esti-
mate than their adjusted counterparts. These differences were remarkably small, < 1%, and
did not have a significant effect on the overall interval length (Table 9). The point estimates
of NPV were 98% when the prevalence was 3%, thus indicating if a patient tested negative
for the ApoE.e4 gene, then the investigator were almost certain that the patient did not have
AD. As the prevalence increased to 50% , then the NPV estimate decreased to 64% while
the PPV estimate increased from 7% to 71%. Regardless of the estimation method, similar
intervals were obtained, which results from the large sample size.
11
http://biostats.bepress.com/uwbiostat/paper271
4.2 Breast Cancer
Breast cancer is the most common cancer among women in the United States, accounting for
almost 30% of all newly diagnosed cancers [16]. It is also the most common cancer in women
worldwide. Various treatment options are available once the diagnosis has been made and
primary tumors are removed. While adjuvant therapy, such as chemotherapy or hormonal
therapy, reduces the risk of distant metastasis, 70% - 80% of patients receiving the treatment
would have survived without it [2]. Accurate prognosis of breast cancer patients, especially
those at early stage and node negative, can help to make correct treatment decisions. Moreover,
many traditional predictors for metastases, such as tumor grade, fail to accurately classify
breast tumors according to their clinical behavior. Recently, several studies have demonstrated
that gene expression profile of tumors removed from breast cancer patients can be utilized for
prognosis of metastasis [2, 14, 15]. van ’t Veer et al. performed a case-control study to develop
a gene signature as a prognosticator of breast cancer patients [2]. Cases were defined as those
that have metastasis within 5 years of tumor excision, while controls were those that did
not. Each tumor was classified as having a good or poor gene signature, or profile, which are
defined as having a signature correlation coefficient above or below the ’optimized sensitivity’
threshold, respectively. This ’optimized sensitivity’ threshold is defined as the the correlation
value that would result in a misclassification of at most 10% of the cases. The performance of
their 70-gene signature as prognosticator for metastasis is summarized in Table 10.
Table 10: Breast Cancer data
Case Control
Poor Signature 31 12
Good Signature 3 32
34 44
From Table 10, the Se of the molecular signature is estimated to be 0.91 (95% CI 0.77-0.97)
while Sp is estimated to be 0.73 (95% CI 0.58-0.84) using the standard method. As in the
example with AD, PPV and NPV cannot be directly estimated as cases that have metastases
in 5 years have been oversampled (43.6% of all samples) as compared to the general population
of breast cancer patients. In their follow-up paper to validate their 70-gene prognosticator of
survival in breast cancer patients, metastasis-free survival rates in 5 years in node negative
patients with tumor excision can be estimated from the supplementary data on their website
[14]. The metastasis-free survival rates in 5 years are estimated to be 70% for all node-negative
patients, 93.4% for patients with good signature, 56.2% for those with bad signature. Based on
these estimates, PPV and NPV of the 70-gene signature will be estimated with prevalences
of 7%, 30%, and 44% for those who metastasize in 5 years.
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Table 11: Breast Cancer Results
Method Estimate 95% CId CI Length Estimate 95% CI CI Length
PPV a NPV a
Standard 0.2010 0.1217-0.2803 0.1586 0.9910 0.9811-1.0010 0.0197
Standard Logit 0.2010 0.1331-0.2919 0.1588 0.9910 0.9734-0.9970 0.0235
Adjusted 0.1837 0.1148-0.2526 0.1377 0.9864 0.9750-0.9977 0.0227
Adjusted Logit 0.1837 0.1245-0.2626 0.1382 0.9864 0.9689-0.9941 0.0252
PPV b NPV b
Standard 0.5889 0.4694-0.7085 0.2390 0.9506 0.8991-1.0020 0.1029
Standard Logit 0.5889 0.4665-0.7013 0.2347 0.9506 0.8654-0.9829 0.1175
Adjusted 0.5617 0.4486-0.6747 0.2261 0.9271 0.8701-0.9841 0.1140
Adjusted Logit 0.5617 0.4474-0.6698 0.2224 0.9271 0.8455-0.9673 0.1218
PPV c NPV c
Standard 0.7243 0.6257-0.8229 0.1972 0.9130 0.8259-1.0000 0.1741
Standard Logit 0.7243 0.6159-0.8114 0.1956 0.9130 0.7781-0.9691 0.1910
Adjusted 0.7014 0.6053-0.7976 0.1923 0.8740 0.7812-0.9669 0.1858
Adjusted Logit 0.7014 0.5975-0.7881 0.1906 0.8740 0.7490-0.9416 0.1926
Prevalence = a0.07, b0.30, c0.44; dCI = confidence interval
As with the AD example, the standard methods produced larger predictive values than the
adjusted estimates ranging in an increase of 0.4%-10% depending on the predictive value and
prevalence value, as well as slightly wider confidence intervals. As expected when the preva-
lence increased so did the PPV estimate, while the NPV estimate decreased. There was not
a clear relationship between interval length and prevalence for PPV , which coincides with
the results from the simulation (Table 5). The interval lengths for NPV estimates do clearly
increase as p increases. There is considerable overlap among the intervals generated by each
method, but intervals associated with the standard estimate should be questioned. The upper
bound for each standard NPV interval borders or exceeds 1, which results from the small
sample sizes.
5 Discussion
Four methods for estimating confidence intervals of predictive values were compared using
coverage probabilities and interval lengths via a simulation study. The methods which were
investigated extended the well received ideas of correcting the standard estimation of a binomial
proportion by incorporating a continuity correction to that of predictive values as well as
performing the logit transformation to minimize the adverse effects of estimating proportions
near 0 and 1. Based on the results of the simulation study, the adjustment using the logit
transformation outperformed the addition of the continuity correction in terms of coverage
probabilities. Interval lengths were fairly uniform across estimation methods and thus did not
enter the decision making process of which method was ’superior’.
Under the evaluated combinations of p, Se, Sp, n0, and n1, the standard logit method
generated overall coverage probabilities greater than its adjusted counterpart. The adjust logit
method is advantageous of the standard logit method in that the requirement of the predictive
value estimate not be 1 is not enforced. The standard logit method is recommended solely
on having a 3.6% greater coverage probability. Both logit methods are preferred over the
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untransformed methods due to the logit method’s inability to create interval bounds outside
the permitted range.
The two examples demonstrated the effects of sample size on the various interval estima-
tion methods. The Alzheimer’s disease example displayed the similarities between estimation
results among each of the evaluated methods when both n0 and n1 were large. The breast
cancer example exemplified the power of the logit function not allowing for the creation of
nonsensical results, standard versus standard logit, when n0 and n1 were small.
Based on these results, if the sample size is ’large enough’, then the estimation method for
a predictive value’s confidence interval varies minutely between the tested estimation meth-
ods. If the sample size is relatively small, as with a binomial proportion, further caution
needs to be applied in the estimation of the predictive value and its confidence interval. This
simulation study provides evidence that the standard logit method may be applicable under
certain circumstances, while the adjusted or adjusted logit method is advantageous in other
circumstances.
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